Unlock instant, AI-driven research and patent intelligence for your innovation.

A cartilage tissue biomimetic matrix and preparation method thereof

A cartilage tissue and matrix technology, applied in the field of cartilage tissue bionic matrix and its preparation, can solve problems such as limited self-healing ability, lack of blood supply, and failure to achieve ideal results for cartilage defects, achieving no rejection and good compatibility Effect

Active Publication Date: 2021-10-22
THE FIRST AFFILIATED HOSPITAL OF ARMY MEDICAL UNIV
View PDF6 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Lack of blood supply in cartilage tissue, resulting in limited ability to heal itself
Traditional classic methods of treating cartilage defects have failed to achieve ideal results

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0024] Chondrocyte culture: the cells were divided into 1×10 5 ~10 6 Cells / ml were seeded in a 10cm cell dish at 37°C, 5% CO 2 They were cultured in a carbon dioxide incubator, and the medium was changed once every 2 days. Cell morphology and growth were observed daily with an inverted microscope. After the cells were fused, they were digested with 0.25% trypsin, subcultured at a ratio of 1:4, cultured for 24-48 hours, digested and collected for later use. The medium is DMEM medium containing 15% fetal bovine serum, 1% glutamine and 1% 50U / mL penicillin and streptomycin.

[0025] After 24 hours of culture, the chondrocytes gradually adhered to the wall. The chondrocytes were elliptical or triangular in shape, with smooth surfaces, increased cell volume, increased cytoplasm, and multiplied vigorously. After 2 days, the cells gradually became dense and fusiform.

Embodiment 2

[0027] a. Polycaprolactone 20g is fully dissolved in 100ml trifluoroethanol to obtain a uniform polycaprolactone solution;

[0028] b. Preparation of chitosan / β-sodium glycerophosphate gel: 4°C-10°C, take 10ml 0.1mol / L β-sodium glycerophosphate solution and add dropwise to 10ml 2% (w / v) chitosan hydrochloric acid solution Stir and mix well, then add 10ml of 20% (w / v) polycaprolactone solution, and finally add the chondrocytes collected by digestion and mix well, the final concentration of cells is 5×10 5 ~10 6 cells / ml, mix the mixture evenly, put it into a 24-well culture plate and let it stand in a 37°C incubator until it solidifies. The configuration of 0.1mol / L β-sodium glycerophosphate solution: Dissolve 21.6g of β-sodium glycerophosphate in 100ml DMEM medium, in which DMEM medium contains 30% fetal bovine serum, 2% glutamine and 2% 50U / mL green , streptomycin, 10ng / ml TGF-β.

[0029] Observe the growth of the cultured cells in the chitosan / β-sodium glycerophosphate ge...

Embodiment 3

[0031] Select 40 clean-grade blue rabbits aged 6-12 months, with a body weight of 1.5-2.0 kg, half male and half male.

[0032] a. Polycaprolactone 25g is fully dissolved in 100ml trifluoroethanol to obtain a uniform polycaprolactone solution;

[0033] b. Preparation of chitosan / beta-glycerophosphate sodium gel: 4°C-10°C, get 10ml 0.1mol / L beta-glycerophosphate sodium solution and add dropwise to 10ml 3% chitosan hydrochloric acid solution, fully stir and mix, Then add 10ml of 25% polycaprolactone solution, and finally add the digested and collected chondrocytes and mix well, the final concentration of cells is 5×10 5 ~10 6 Cells / ml was calculated and the mixture was mixed evenly before use. The configuration of 0.1mol / L β-sodium glycerophosphate solution: Dissolve 21.6g of β-sodium glycerophosphate in 100ml DMEM medium, DMEM medium contains 30% fetal bovine serum, 2% glutamine and 2% 50U / mL green, Streptomycin, 10 ng / ml TGF-β.

[0034] Animal model preparation and experim...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a cartilage tissue bionic matrix and a preparation method thereof. The cartilage tissue bionic matrix is ​​composed of polycaprolactone, chitosan, β-glycerophosphate sodium and chondrocytes; After the sodium reaction, add polycaprolactone and mix well, and then mix chondrocytes into the compound. Finally, the cells can have good compatibility with the composite material, and the biological activity of the cells can be fully displayed in the animal body without rejection. reaction. A cartilage biomimetic matrix that can be injected and implanted by 3D printing is provided.

Description

technical field [0001] The invention belongs to the fields of biological tissue bionic engineering and biological 3D printing, and relates to a cartilage tissue bionic matrix and a preparation method thereof. Background technique [0002] It has been more than 20 years since the first application of tissue engineering technology. It is not only used in tissue and organ repair and regeneration, but also in cell behavior research and drug screening. With the development of science and technology, many new ideas and technologies have been introduced into the field of tissue engineering. The bio-3D printing technology that has emerged in recent years has developed rapidly in the field of tissue engineering. It can realize bio-3D printing by constructing three-dimensional and complex scaffold models, which can better simulate the cellular microenvironment, and is high-throughput and reproducible. , automation, precision and controllability, etc., and can also provide personalize...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61L27/18A61L27/20A61L27/38A61L27/54
CPCA61L27/18A61L27/20A61L27/3817A61L27/54A61L2300/30A61L2300/412A61L2400/06A61L2430/06C08L67/04C08L5/08
Inventor 王富友张颖陈光兴杨柳
Owner THE FIRST AFFILIATED HOSPITAL OF ARMY MEDICAL UNIV